Successful clinical trial for re-engineered UQ vaccine

re-engineered

Successful clinical trial for re-engineered UQ vaccine: The University of Queensland’s re-engineered clamp platform has produced a vaccine that is equally safe and virus-neutralising as an approved vaccine considered among the best in its class. The pivotal proof-of-concept testing clears the way to progress the promising Clamp2 technology in a range of research programs. Project […]

Read More… from Successful clinical trial for re-engineered UQ vaccine

Update on The University of Queensland COVID-19 vaccine

strong support

Friday, 11th December, 2020: The University of Queensland (UQ) and CSL today announce that the Phase 1 trial of the UQ-CSL v451 COVID-19 vaccine has shown that it elicits a robust response towards the virus and has a strong safety profile. There were no serious adverse events or safety concerns reported in the 216 trial participants. However, […]

Read More… from Update on The University of Queensland COVID-19 vaccine